CellNovo raised €35M in a Series B round in Feb 2011. The company is based in Kings Road Swansea Waterfront, UK. Investors in the round: Advent Venture Partners, Forbion Capital Partners, NBGI Ventures and 1 other. Data as of 6 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
